Literature DB >> 21239487

Reconstitution of insulin action in muscle, white adipose tissue, and brain of insulin receptor knock-out mice fails to rescue diabetes.

Hua V Lin1, Domenico Accili.   

Abstract

Type 2 diabetes results from an impairment of insulin action. The first demonstrable abnormality of insulin signaling is a decrease of insulin-dependent glucose disposal followed by an increase in hepatic glucose production. In an attempt to dissect the relative importance of these two changes in disease progression, we have employed genetic knock-outs/knock-ins of the insulin receptor. Previously, we demonstrated that insulin receptor knock-out mice (Insr(-/-)) could be rescued from diabetes by reconstitution of insulin signaling in liver, brain, and pancreatic β cells (L1 mice). In this study, we used a similar approach to reconstitute insulin signaling in tissues that display insulin-dependent glucose uptake. Using GLUT4-Cre mice, we restored InsR expression in muscle, fat, and brain of Insr(-/-) mice (GIRKI (Glut4-insulin receptor knock-in line 1) mice). Unlike L1 mice, GIRKI mice failed to thrive and developed diabetes, although their survival was modestly extended when compared with Insr(-/-). The data underscore the role of developmental factors in the presentation of murine diabetes. The broader implication of our findings is that diabetes treatment should not necessarily target the same tissues that are responsible for disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239487      PMCID: PMC3059034          DOI: 10.1074/jbc.M110.210807

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

Authors:  I Shimomura; M Matsuda; R E Hammer; Y Bashmakov; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

Review 2.  Distinct and overlapping functions of insulin and IGF-I receptors.

Authors:  J Nakae; Y Kido; D Accili
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

3.  Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain.

Authors:  Raman Sankar; Shanthie Thamotharan; Don Shin; Kelle H Moley; Sherin U Devaskar
Journal:  Brain Res Mol Brain Res       Date:  2002-11-15

4.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats.

Authors:  Silvana Obici; Zhaohui Feng; George Karkanias; Denis G Baskin; Luciano Rossetti
Journal:  Nat Neurosci       Date:  2002-06       Impact factor: 24.884

5.  Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistance.

Authors:  Yoshiaki Kido; Jun Nakae; Marta Letizia Hribal; Shouhong Xuan; Argiris Efstratiadis; Domenico Accili
Journal:  J Biol Chem       Date:  2002-07-05       Impact factor: 5.157

6.  Mosaic analysis of insulin receptor function.

Authors:  Tadahiro Kitamura; Yukari Kitamura; Jun Nakae; Antonio Giordano; Saverio Cinti; C Ronald Kahn; Argiris Efstratiadis; Domenico Accili
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 7.  In vivo mutagenesis of the insulin receptor.

Authors:  Haruka Okamoto; Domenico Accili
Journal:  J Biol Chem       Date:  2003-06-04       Impact factor: 5.157

8.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.

Authors:  Matthias Blüher; M Dodson Michael; Odile D Peroni; Kohjiro Ueki; Nathan Carter; Barbara B Kahn; C Ronald Kahn
Journal:  Dev Cell       Date:  2002-07       Impact factor: 12.270

9.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

Authors:  Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

10.  Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues.

Authors:  Hua V Lin; Hongxia Ren; Varman T Samuel; Hui-Young Lee; Taylor Y Lu; Gerald I Shulman; Domenico Accili
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

View more
  9 in total

1.  Molecular Basis of Insulin Resistance: The Role of IRS and Foxo1 in the Control of Diabetes Mellitus and Its Complications.

Authors:  Shaodong Guo
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

Review 2.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

3.  Restoration of insulin receptor improves diabetic phenotype in T2DM mice.

Authors:  Yichen Wang; Heather Zhou; Oksana Palyha; James Mu
Journal:  JCI Insight       Date:  2019-08-08

Review 4.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 5.  Mouse models and type 2 diabetes: translational opportunities.

Authors:  Fiona McMurray; Roger D Cox
Journal:  Mamm Genome       Date:  2011-06-29       Impact factor: 2.957

Review 6.  Brain insulin signalling in metabolic homeostasis and disease.

Authors:  Thomas Scherer; Kenichi Sakamoto; Christoph Buettner
Journal:  Nat Rev Endocrinol       Date:  2021-06-09       Impact factor: 43.330

Review 7.  Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models.

Authors:  Brian T DeCant; Daniel R Principe; Carmen Guerra; Marina Pasca di Magliano; Paul J Grippo
Journal:  Front Physiol       Date:  2014-12-04       Impact factor: 4.566

Review 8.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01

Review 9.  Recent progress in metabolic signaling pathways regulating aging and life span.

Authors:  Christopher B Newgard; Jeffrey E Pessin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.